MGNX
MacroGenics Inc
NASDAQ: MGNX · HEALTHCARE · BIOTECHNOLOGY
$3.08
+4.76% today
Updated 2026-04-30
Market cap
$193.86M
P/E ratio
—
P/S ratio
1.30x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$1 – $4
Volume
1.1M
MacroGenics Inc (MGNX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+41.5%
Last 4 quarters
Revenue YoY growth
+132.5%
Most recent quarter
EPS YoY growth
+73.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+5.3%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $-0.22 | +18.4% | $1.70 | $1.70 | +0.0% |
| 2025-11-12 | $0.27 | +165.9% | $1.52 | $1.60 | +5.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.27 | $-0.22 | +18.4% | $41.23M | +132.5% |
| 2025-09-30 | $-0.41 | $0.27 | +165.9% | $72.84M | -34.2% |
| 2025-06-30 | $-0.46 | $-0.57 | -23.9% | $22.24M | +106.0% |
| 2025-03-31 | $-0.69 | $-0.65 | +5.8% | $13.19M | +44.9% |
| 2024-12-31 | $-0.59 | $-0.82 | -38.6% | $17.73M | +65.4% |
| 2024-09-30 | $0.21 | $0.90 | +328.6% | $110.71M | +964.8% |
| 2024-06-30 | $-0.59 | $-0.89 | -50.8% | $10.80M | -17.8% |
| 2024-03-31 | $-0.64 | $-0.84 | -31.2% | $9.10M | -62.8% |
| 2023-12-31 | $-0.15 | $-0.75 | -400.0% | $10.72M | — |
| 2023-09-30 | $-0.10 | $0.28 | +380.0% | $10.40M | — |
| 2023-06-30 | $-0.52 | $-0.69 | -32.7% | $13.14M | — |
| 2023-03-31 | $0.45 | $-0.61 | -235.6% | $24.50M | — |
| 2022-12-31 | $0.10 | $0.21 | +110.0% | — | — |
Frequently asked questions
Has MacroGenics Inc beaten earnings estimates?
MacroGenics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +41.5% over the last 4 quarters.
How does MGNX stock react to earnings?
MGNX stock has moved an average of +2.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is MacroGenics Inc's revenue growth rate?
MacroGenics Inc reported year-over-year revenue growth of +132.5% in its most recent quarter, with EPS growing +73.1% year-over-year.